As drug makers seek wider latitude to promote their medicines, Tennessee has become the second state in the U.S. to enact a law allowing the companies to market their products for so-called off-label uses — so long as the information given doctors is truthful.
The law, which goes into effect on July 1, arrives more than a year after Arizona adopted the first such law in the country. Moreover, it comes amid rising pressure on the Food and Drug Administration to loosen regulations for off-label promotions, which is one of the most contentious issues to roil both the agency and the pharmaceutical industry.
At issue is a fierce debate over patient safety and free speech.
About the Author Reprints
